Front. Immunol.Frontiers in ImmunologyFront. Immunol.1664-3224Frontiers Media S.A.10.3389/fimmu.2025.1632381ImmunologyCorrectionCorrection: Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technologyZhouXinyao1†WangWuqian23†ChenLuan3YangYingjun4WeiXing1ZhouJia1SunKuan1TangPing5SunXiaofang2QinShengying3*SunLuming46*1Department of Fetal Medicine & Prenatal Diagnosis Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China2Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China3Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China4Department of Obstetrics, Center of Fetal Medicine & Intrauterine Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China5Jiaxing Maternity and Children Health Care Hospital, Affiliated Women and Children Hospital, Jiaxing University, Jiaxing, Zhejiang, China6School of Medicine, Tongji University, Shanghai, China
Edited and Reviewed by: David Cameron Wraith, University of Birmingham, United Kingdom
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Correction on Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology By Zhou X, Wang W, Chen L, Yang Y, Wei X, Zhou J, Sun K, Tang P, Sun X, Qin S and Sun L (2025). Front. Immunol. 16:1542034. doi: 10.3389/fimmu.2025.1542034fetal growth restriction (FGR)Olink proteomics platformproximity extension assay (PEA)biomarkerstargeted proteomics analysissection-in-acceptanceImmunological Tolerance and Regulation
In the published article, there was an error in Figure 2B as published. Incorrect values were displayed on the pie chart. The corrected Figure 2 and its caption “Figure 2 Descriptive statistics of clinical information of FGR patients. (A) Gestational Week for Collection of Maternal Peripheral Blood for FGR patients and control samples; (B) Blood flow conditions for FGR patients; (C) Combined symptoms for FGR patients” appear below.
Descriptive statistics of clinical information of FGR patients. (A) Gestational Week for Collection of Maternal Peripheral Blood for FGR patients and control samples; (B) Blood flow conditions for FGR patients; (C) Combined symptoms for FGR patients.
Panel A is a line graph showing gestational weeks for collecting maternal peripheral blood, comparing FGR and control groups. Panel B is a pie chart depicting blood flow conditions with four segments: mild abnormalities (37%), persistent absence (43%), reversed flow (9%), and intermittent absence (11%). Panel C is a bar chart displaying combined symptoms, highlighting conditions like preeclampsia and gestational diabetes mellitus with varying frequencies.
The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.